Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis

[1]  R. Rupprecht,et al.  Enhancing Neurosteroid Synthesis – Relationship to the Pharmacology of Translocator Protein (18 kDa) (TSPO) Ligands and Benzodiazepines , 2015, Pharmacopsychiatry.

[2]  Y. Izumi,et al.  Neurosteroids are endogenous neuroprotectants in an ex vivo glaucoma model. , 2014, Investigative ophthalmology & visual science.

[3]  A. Walf,et al.  Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptor , 2014, Front. Cell. Neurosci..

[4]  M. Schumacher,et al.  Revisiting the roles of progesterone and allopregnanolone in the nervous system: Resurgence of the progesterone receptors , 2014, Progress in Neurobiology.

[5]  L. Garcia-Segura,et al.  Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions , 2014, Progress in Neurobiology.

[6]  D. Walker,et al.  Neuroactive steroids in pregnancy: Key regulatory and protective roles in the foetal brain , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  Massimo Masserini,et al.  Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor , 2014, Front. Cell. Neurosci..

[8]  D. Reddy,et al.  Erratum to: Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability , 2013, Psychopharmacology.

[9]  W. Deng,et al.  A TSPO ligand is protective in a mouse model of multiple sclerosis , 2013, EMBO molecular medicine.

[10]  K. Fukunaga,et al.  Stimulation of the Sigma-1 Receptor by DHEA Enhances Synaptic Efficacy and Neurogenesis in the Hippocampal Dentate Gyrus of Olfactory Bulbectomized Mice , 2013, PloS one.

[11]  M. E. Brocca,et al.  Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis , 2012, Neuroscience.

[12]  P. Thomas,et al.  Membrane Progesterone Receptors: Evidence for Neuroprotective, Neurosteroid Signaling and Neuroendocrine Functions in Neuronal Cells , 2012, Neuroendocrinology.

[13]  M. Schumacher,et al.  Progesterone Synthesis in the Nervous System: Implications for Myelination and Myelin Repair , 2011, Front. Neurosci..

[14]  L. Steinman,et al.  Impaired neurosteroid synthesis in multiple sclerosis. , 2011, Brain : a journal of neurology.

[15]  Ming-de Wang.  Neurosteroids and GABA-A Receptor Function , 2011, Front. Endocrin..

[16]  Gerhard Rammes,et al.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders , 2010, Nature Reviews Drug Discovery.

[17]  W. Shen,et al.  Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones , 2010, Nutrition & metabolism.

[18]  Guo-dong Liu,et al.  Progesterone attenuates neurological behavioral deficits of experimental autoimmune encephalomyelitis through remyelination with nucleus-sublocalized Olig1 protein , 2010, Neuroscience Letters.

[19]  Lulu Chen,et al.  Effect of catch-up growth after food restriction on the entero-insular axis in rats , 2010, Nutrition & metabolism.

[20]  H. Offner,et al.  Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis , 2010, Journal of Neuroimmunology.

[21]  Melissa Miranda,et al.  Inhibitory role for GABA in autoimmune inflammation , 2010, Proceedings of the National Academy of Sciences.

[22]  M. Donia,et al.  Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis , 2010, Clinical and experimental immunology.

[23]  L. Garcia-Segura,et al.  Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels , 2010, Neurochemistry International.

[24]  M. Meyer,et al.  Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis , 2009, Brain Research.

[25]  H. Vaudry,et al.  Neurosteroid biosynthesis: Enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides , 2009, Frontiers in Neuroendocrinology.

[26]  C. Caligioni.  Assessing Reproductive Status/Stages in Mice , 2009, Current protocols in neuroscience.

[27]  M. Gavish,et al.  CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells. , 2009, Biochemistry.

[28]  V. Vladimirov,et al.  Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects , 2009 .

[29]  Song Liu,et al.  Etifoxine improves peripheral nerve regeneration and functional recovery , 2008, Proceedings of the National Academy of Sciences.

[30]  M. Gavish,et al.  VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis , 2008, Journal of bioenergetics and biomembranes.

[31]  G. Panzica,et al.  The endocrine nervous system: Source and target for neuroactive steroids , 2008, Brain Research Reviews.

[32]  P. Zheng,et al.  Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors , 2008, Experimental Neurology.

[33]  L. Garay,et al.  Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[34]  C. A. Foster,et al.  FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis , 2007, Brain Research Bulletin.

[35]  V. Papadopoulos,et al.  Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. , 2007, Current pharmaceutical design.

[36]  L. Garcia-Segura,et al.  Steroids and glial cell function , 2006, Glia.

[37]  D. Kipnis,et al.  Pregnane X receptor (PXR) activation: A mechanism for neuroprotection in a mouse model of Niemann–Pick C disease , 2006, Proceedings of the National Academy of Sciences.

[38]  M. Schumacher,et al.  Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry. , 2006, Endocrinology.

[39]  V. Papadopoulos,et al.  Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders , 2006, Neuroscience.

[40]  M. Schumacher,et al.  The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain , 2005, Pharmacology Biochemistry and Behavior.

[41]  L. Partridge,et al.  Pregnenolone sulfate acts through a G-protein-coupled sigma1-like receptor to enhance short term facilitation in adult hippocampal neurons. , 2005, European journal of pharmacology.

[42]  J. Lambert,et al.  Neurosteroids: endogenous regulators of the GABAA receptor , 2005, Nature Reviews Neuroscience.

[43]  M. Schumacher,et al.  Novel lipoidal derivatives of pregnenolone and dehydroepiandrosterone and absence of their sulfated counterparts in rodent brain Published, JLR Papers in Press, September 1, 2004. DOI 10.1194/jlr.M400244-JLR200 , 2004, Journal of Lipid Research.

[44]  S. Kurumiya,et al.  Antianxiety and antidepressant‐like effects of AC‐5216, a novel mitochondrial benzodiazepine receptor ligand , 2004, British journal of pharmacology.

[45]  A. Morel,et al.  The modulatory effects of the anxiolytic etifoxine on GABAA receptors are mediated by the β subunit , 2003, Neuropharmacology.

[46]  S. Galiègue,et al.  Peripheral benzodiazepine receptors and mitochondrial function , 2002, Neurochemistry International.

[47]  K. Ukena,et al.  Effects of Progesterone Synthesized De Novo in the Developing Purkinje Cell on Its Dendritic Growth and Synaptogenesis , 2001, The Journal of Neuroscience.

[48]  V. Rybalchenko,et al.  Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine , 2000, Neuropharmacology.

[49]  M. Schumacher,et al.  Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination. , 2000, Steroids.

[50]  M. Schumacher,et al.  Validation of an analytical procedure to measure trace amounts of neurosteroids in brain tissue by gas chromatography-mass spectrometry. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[51]  V. Papadopoulos,et al.  Peripheral-Type Benzodiazepine Receptor , 1999 .

[52]  G. Brewer,et al.  Optimized survival of hippocampal neurons in B27‐supplemented neurobasal™, a new serum‐free medium combination , 1993, Journal of neuroscience research.

[53]  E. Costa,et al.  Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Hirsch,et al.  Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. , 1989, Molecular pharmacology.

[55]  D. Choi.  Ionic dependence of glutamate neurotoxicity , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[56]  K. McCarthy,et al.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue , 1980, The Journal of cell biology.